Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Bullboard Posts
Comment by wildbird1on Sep 06, 2019 11:50am
126 Views
Post# 30102543

RE:RE:RE:RE:GRAIL VS Stagezero

RE:RE:RE:RE:GRAIL VS Stagezero
If I might add, in the Apr. 3, 2019 "Earning Call Transcripts", J. Tripp said (QUOTE) " Our science is therefore definitively proven, it is not promised. And I'm going to come back to that, it is proven, it's not promised. Remember that the competitors in our space are still working on the science , we are not, ours works (END OF QUOTE).

This Quote say's a lot's about the lead SZLS has on everybody else, concerning " Cancer Blood Tests".


Nailbiter1 wrote: This was the email I got back in Sept, 2018...................

CancerSEEK is interesting, but is still early and will need a lot of validation work.

We have our own program called Aristotle, started some years ago, that identifies multiple diseases including 8-10 cancers. It is more advanced than CancerSeek. We are working on a new publication now and will make some noise when we publish.

We are looking to take it forward as a full program

James R Howard-Tripp,
Chairman and CEO,
GeneNews Ltd.


............... Also, on the old Genenews website there was a section called "Our Pipeline" where you could see the 5 phases of Aristotle.

phase 1 cancer
phase 2 gastrointestinal
phase 3 neuroscience
phase 4 cardiovascular
phase 5 musculoskeletal


SAGDollar wrote: It's amazing the vastness of the Aristotle test considering the phases and spectrum of detection. I didn't know the details of the phases, thanks for the details on that. Ironically enough I was listening to a Joe Rogan podcast #1345 last night with Steve Aioki and they were talking about cancer detection and general life sciences and I wish I could have yelled through the radio of my pickup lol. It would be amazing publicity for Stagezero if they could ever get to the attention of that man or any one with similar publicity, reputation and social status.




Bullboard Posts